Healthy Life Agritec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003675,
    "name": "Healthy Life",
    "stock_name": "Healthy Life",
    "full_name": "Healthy Life Agritec Ltd",
    "name_url": "stocks-analysis/healthy-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.36",
    "chg": 0.44,
    "chgp": "4.93%",
    "dir": 1,
    "prev_price": "8.92",
    "mcapval": "44.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543546,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE0L3501015",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 10000,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/healthy-life-1003675-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Healthy Life overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthy-life-overvalued-or-undervalued-3713639",
        "imagepath": "",
        "date": "2025-11-19 08:10:01",
        "description": "As of 18 November 2025, the valuation grade for Healthy Life has moved from very attractive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.90, an EV to EBITDA of 16.07, and a ROCE of 10.96%. \n\nIn comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 53.39 and Nestle India's 81.48, both of which are categorized as very expensive. Despite this, Healthy Life's current valuation does not justify its price, especially given its recent stock performance, which has seen a drastic decline of 72.29% year-to-date, contrasting sharply with the Sensex's 8.36% gain in the same period...."
      },
      {
        "title": "How has been the historical performance of Healthy Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-healthy-life-3704152",
        "imagepath": "",
        "date": "2025-11-15 00:26:58",
        "description": "Answer:\nThe historical performance of Healthy Life shows significant growth over the years, particularly in net sales and profitability.\n\nBreakdown:\nHealthy Life's net sales have increased from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25. The company's total expenditure also grew, from 32.78 Cr in Mar'22 to 166.98 Cr in Mar'25, but the operating profit (PBDIT) improved from 1.18 Cr to 4.89 Cr during the same period, indicating enhanced operational efficiency. Profit before tax rose from 1.12 Cr in Mar'22 to 4.35 Cr in Mar'25, while profit after tax increased from 0.83 Cr to 3.26 Cr, showcasing a consistent improvement in profitability. The earnings per share (EPS) fluctuated, reaching 0.83 in Mar'25, down from 1.14 in Mar'24. On the balance sheet, total assets grew..."
      },
      {
        "title": "When is the next results date for Healthy Life?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-healthy-life-3691259",
        "imagepath": "",
        "date": "2025-11-11 23:20:31",
        "description": "The next results date for Healthy Life is scheduled for 14 November 2025...."
      },
      {
        "title": "Is Healthy Life overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthy-life-overvalued-or-undervalued-3684222",
        "imagepath": "",
        "date": "2025-11-10 08:12:58",
        "description": "As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in perception regarding its market value. The company is currently assessed as undervalued, particularly when considering its PE ratio of 26.24, EV to EBITDA of 17.44, and ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics stand out; for instance, Hindustan Unilever has a PE ratio of 53.63 and Nestle India has a PE of 81.21, both categorized as very expensive.\n\nDespite the recent downturn in stock performance with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's attractive valuation suggests potential for recovery. The company's EV to Sales ratio of 0.50 further supports the argument for undervaluation, especially when juxtaposed against its peers, many of which exhibit significantly higher valuation multiples...."
      },
      {
        "title": "Is Healthy Life overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthy-life-overvalued-or-undervalued-3682900",
        "imagepath": "",
        "date": "2025-11-09 08:11:12",
        "description": "As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, with a PE ratio of 26.24, an EV to EBITDA ratio of 17.44, and a ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics are significantly lower; for instance, Hindustan Unilever has a PE ratio of 53.63, while Nestle India stands at 81.21.\n\nDespite the recent decline in stock performance, with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's current valuation appears attractive relative to its peers in the FMCG sector. The company's EV to Sales ratio of 0.50 further supports the notion of undervaluation, especially when juxtaposed against competitors like Britannia Industries, which has a much higher valuation. Overall, Healthy Life presents a compelling investment oppo..."
      },
      {
        "title": "Is Healthy Life overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthy-life-overvalued-or-undervalued-3681924",
        "imagepath": "",
        "date": "2025-11-08 08:11:04",
        "description": "As of 7 November 2025, the valuation grade for Healthy Life has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as overvalued. Key ratios include a PE ratio of 26.24, an EV to EBITDA of 17.44, and a ROCE of 13.87%. \n\nIn comparison to its peers, Healthy Life's PE ratio is significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both categorized as very expensive. Despite this, the company's valuation appears stretched given its current performance and the broader market context. Notably, Healthy Life has underperformed the Sensex over the past year, with a return of -48.38% compared to the Sensex's 4.62%, reinforcing the notion of its overvaluation...."
      }
    ],
    "total": 97,
    "sid": "1003675",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/healthy-life-agritec-1003675"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "21-Jan-2026",
      "details": "Please find enclosed herewith certificate under regulation 74(5) of SEBI(DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation of closure of trading window pursuant to SEBI PIT Regulation 2015",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Unaudited Consolidated And Standalone Financial Results For The Half- Year Ended 30 September 2025 Pursuant To Regulation 33 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015",
      "datetime": "14-Nov-2025",
      "details": "Approval of Unaudited Financial Results for the period ended 30 September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Healthy Life Agritec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 26 Sep 25",
          "dt": "2025-09-26",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Is Healthy Life overvalued or undervalued?

2025-11-19 08:10:01

As of 18 November 2025, the valuation grade for Healthy Life has moved from very attractive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.90, an EV to EBITDA of 16.07, and a ROCE of 10.96%. In comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 53.39 and Nestle India's 81.48, both of which are categorized as very expensive. Despite this, Healthy Life's current valuation does not justify its price, especially given its recent stock performance, which has seen a drastic decline of 72.29% year-to-date, contrasting sharply with the Sensex's 8.36% gain in the same period....

How has been the historical performance of Healthy Life?

2025-11-15 00:26:58

Answer: The historical performance of Healthy Life shows significant growth over the years, particularly in net sales and profitability. Breakdown: Healthy Life's net sales have increased from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25. The company's total expenditure also grew, from 32.78 Cr in Mar'22 to 166.98 Cr in Mar'25, but the operating profit (PBDIT) improved from 1.18 Cr to 4.89 Cr during the same period, indicating enhanced operational efficiency. Profit before tax rose from 1.12 Cr in Mar'22 to 4.35 Cr in Mar'25, while profit after tax increased from 0.83 Cr to 3.26 Cr, showcasing a consistent improvement in profitability. The earnings per share (EPS) fluctuated, reaching 0.83 in Mar'25, down from 1.14 in Mar'24. On the balance sheet, total assets grew...

When is the next results date for Healthy Life?

2025-11-11 23:20:31

The next results date for Healthy Life is scheduled for 14 November 2025....

Is Healthy Life overvalued or undervalued?

2025-11-10 08:12:58

As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in perception regarding its market value. The company is currently assessed as undervalued, particularly when considering its PE ratio of 26.24, EV to EBITDA of 17.44, and ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics stand out; for instance, Hindustan Unilever has a PE ratio of 53.63 and Nestle India has a PE of 81.21, both categorized as very expensive. Despite the recent downturn in stock performance with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's attractive valuation suggests potential for recovery. The company's EV to Sales ratio of 0.50 further supports the argument for undervaluation, especially when juxtaposed against its peers, many of which exhibit significantly higher valuation multiples....

Is Healthy Life overvalued or undervalued?

2025-11-09 08:11:12

As of 7 November 2025, Healthy Life's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, with a PE ratio of 26.24, an EV to EBITDA ratio of 17.44, and a ROCE of 13.87%. In comparison to its peers, Healthy Life's valuation metrics are significantly lower; for instance, Hindustan Unilever has a PE ratio of 53.63, while Nestle India stands at 81.21. Despite the recent decline in stock performance, with a year-to-date return of -66.81% compared to the Sensex's 6.50%, Healthy Life's current valuation appears attractive relative to its peers in the FMCG sector. The company's EV to Sales ratio of 0.50 further supports the notion of undervaluation, especially when juxtaposed against competitors like Britannia Industries, which has a much higher valuation. Overall, Healthy Life presents a compelling investment oppo...

Is Healthy Life overvalued or undervalued?

2025-11-08 08:11:04

As of 7 November 2025, the valuation grade for Healthy Life has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as overvalued. Key ratios include a PE ratio of 26.24, an EV to EBITDA of 17.44, and a ROCE of 13.87%. In comparison to its peers, Healthy Life's PE ratio is significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both categorized as very expensive. Despite this, the company's valuation appears stretched given its current performance and the broader market context. Notably, Healthy Life has underperformed the Sensex over the past year, with a return of -48.38% compared to the Sensex's 4.62%, reinforcing the notion of its overvaluation....

View All News